McGovern Fellow/Principal Investigator
Omar Abudayyeh is a McGovern Institute Fellow at MIT where he directs a lab exploring microbial diversity for developing next-generation cell profiling, gene editing and gene delivery technologies. These tools, including the popular gene editing system CRISPR, allow for unprecedented manipulation and profiling of cellular states with multiple applications in basic science and for programmable therapeutics and diagnostics. He previously was at Harvard Medical School and MIT as a graduate student in Feng Zhang’s lab at the Broad Institute, where his research centered on novel CRISPR enzymes for genome editing, therapeutics, and diagnostics. He is also co-founder of Sherlock Biosciences, which is commercializing CRISPR-based diagnostics for healthcare. Dr. Abudayyeh was recognized as 2018 Forbes 30 under 30 and a 2013 Paul and Daisy Soros Fellowship. Dr. Abudayyeh graduated from MIT in 2012 with a B.S. in mechanical engineering and biological engineering.
Thursday, July 30, 2020
10:40 AM – 11:10 AM EDT